Anish Suri

Anish Suri

Former President and Chief Scientific OfficeratCue Biopharma· In proxies 2022–2024

Pay in FY2024-5% from the year before · Cue Biopharma stock -58.7% the same year

Anish Suri was paid $1.2M in FY2024 (Dec), down 5%. Cue Biopharma stock fell 58.7% that year.

Pay$100 in the stock at the end of FY21 → $10
Pay is from the Summary Compensation Table of each Cue Biopharma proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Cue BiopharmaPublic company · 4 yr
    • Former President and Chief Scientific Officer2022 – Present · 4 yrStock in role -94%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?